NGM

NGM Biopharmaceuticals, Inc. Common Stock
NGM

Overview Fund Activity
Delisted

NGM was delisted on the 4th of April, 2024.

Back to rankings

51 hedge funds and large institutions have $365M invested in NGM Biopharmaceuticals, Inc. Common Stock in 2019 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 21 increasing their positions, 9 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
51
Holders Change
+3
Holders Change %
+6.25%
% of All Funds
1.12%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
12
Increased
21
Reduced
9
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
PS
Peter Svennilson
$224M
2
BlackRock
BlackRock
New York
$9.06M
3
Victory Capital Management
Victory Capital Management
Texas
$4.4M
4
Northern Trust
Northern Trust
Illinois
$1.4M
5
EIM
Essex Investment Management
Massachusetts
$621K

Top Sellers

1
FCMI
Foresite Capital Management IV
California
$0
2
EC
EcoR1 Capital
California
$0
3
Alyeska Investment Group
Alyeska Investment Group
Illinois
$0
4
AG
Artal Group
Luxembourg
$0
5
SSA
Schonfeld Strategic Advisors
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
PS
1
Peter Svennilson
$224M +$6.55M +472,816 +3%
RCP
2
Rho Capital Partners
New York
$52.2M – – –
GA
3
Greenspring Associates
Maryland
$21.8M – – –
Royal Bank of Canada
4
Royal Bank of Canada
Ontario, Canada
$16.7M -$914 -66 -0%
BlackRock
5
BlackRock
New York
$9.06M +$4.62M +333,604 +104%
RSCM
6
Rock Springs Capital Management
Maryland
$4.86M – – –
JRP
7
Jasper Ridge Partners
California
$4.85M +$13.9K +1,000 +0.3%
Victory Capital Management
8
Victory Capital Management
Texas
$4.4M +$2.63M +189,566 +148%
HM
9
HealthCor Management
New York
$4.39M -$359K -25,900 -8%
Fidelity Investments
10
Fidelity Investments
Massachusetts
$3.99M – – –
BBA
11
Baker Bros. Advisors
New York
$3.46M – – –
Vanguard Group
12
Vanguard Group
Pennsylvania
$2.38M +$51.2K +3,695 +2%
CS
13
Candriam SCA
Luxembourg
$2.15M +$277K +20,000 +15%
State Street
14
State Street
Massachusetts
$1.8M +$564K +40,725 +46%
Northern Trust
15
Northern Trust
Illinois
$1.4M +$763K +55,145 +120%
Geode Capital Management
16
Geode Capital Management
Massachusetts
$1.31M -$65.7K -4,750 -5%
Goldman Sachs
17
Goldman Sachs
New York
$755K -$23.4K -1,691 -3%
EIM
18
Essex Investment Management
Massachusetts
$621K +$621K +44,805 New
Charles Schwab
19
Charles Schwab
California
$561K +$27.4K +1,974 +5%
Barclays
20
Barclays
United Kingdom
$401K -$5.23K -377 -1%
HSBC Holdings
21
HSBC Holdings
United Kingdom
$363K +$363K +26,236 New
Bank of New York Mellon
22
Bank of New York Mellon
New York
$345K +$179K +12,928 +108%
Nuveen Asset Management
23
Nuveen Asset Management
Illinois
$330K +$191K +13,818 +138%
Citadel Advisors
24
Citadel Advisors
Florida
$325K +$51.4K +3,700 +19%
Morgan Stanley
25
Morgan Stanley
New York
$301K +$301K +21,697 +86,788%
1
2 3